10 Eli Lilly leaders in new roles in 2026
Each of these ten Eli Lilly leaders in new roles in 2026 started their current Eli Lilly title in 2026, from vice presidents and site heads in manufacturing to directors of engineering and finance. A reader can learn how Eli Lilly leaders approach a role they started in 2026 from people who hold one now.
Professionals to explore
Ahmad Tarek
LinkedInExperience: Associate Vice President · Eli Lilly and Company
Ahmad Tarek has been Associate Vice President at Eli Lilly and Company since May 2026, based in Durham, North Carolina, and also lists Executive Director Parenteral Manufacturing Operations at Eli Lilly and Company from January 2026. At Eli Lilly and Company, Ahmad Tarek was also Executive Director and RTP Site Quality Leader in 2025 and Executive Director IPM Quality for Multi-Product Plant in 2025.
Andrew McLeish, MBA
LinkedInExperience: Director of Engineering and Facilities · Eli Lilly and Company
Andrew McLeish has been Director of Engineering and Facilities at Eli Lilly and Company since February 2026, based in Greater Indianapolis. Andrew McLeish was also Associate Director of Engineering and Maintenance at Eli Lilly and Company from 2024 to 2026 and Senior Manager Engineering and Maintenance at POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company, from 2023 to 2024.
Anna Adeniran- Badiru
LinkedInExperience: Executive Director · Eli Lilly and Company
Anna Adeniran- Badiru has been Executive Director at Eli Lilly and Company since March 2026, based in the Charlotte area. Anna Adeniran- Badiru was also Senior Director of Finance, Procurement & Competitive Continuous Improvement at Eli Lilly and Company from 2023 to 2026 and Finance Manager, Middle Mile Product and Technology at Amazon from 2020 to 2023.
Donough Ruane
LinkedInExperience: Senior Director Finance · Eli Lilly and Company
Donough Ruane has been Senior Director Finance at Eli Lilly and Company since July 2026, based in Cork, Ireland, and describes driving cost competitiveness and strategic positioning for a large-scale pharmaceutical manufacturing site. Donough Ruane was also Associate Director Financial Planning & Reporting at Eli Lilly and Company from 2025 to 2026 and Head FP&A (BPA) Large Molecules at Novartis from 2023 to 2025.
Elsa Ileana Orbe
LinkedInExperience: Director FP&A, Treasury and BD · Eli Lilly and Company
Elsa Ileana Orbe has been Director FP&A, Treasury and BD at Eli Lilly and Company since January 2026, based in Mexico City. At Eli Lilly and Company, Elsa Ileana Orbe was also Director Financial Planning LATAM in 2025, Associate Director - Forecasting & Supply LATAM from 2024 to 2025 and Associate Director - Forecasting & Replenishment México (Supply) from 2022 to 2024.
Graciela M. Romero
LinkedInExperience: Vice President, Site Head, Lilly Huntsville · Eli Lilly and Company
Graciela M. Romero has been Vice President, Site Head, Lilly Huntsville at Eli Lilly and Company since June 2026, based in the United States. At Eli Lilly and Company, Graciela M. Romero was also Vice President of Quality - Indianapolis Parenteral Manufacturing in 2026, Assoc. Vice President Quality - Indianapolis Parenteral Manufacturing from 2023 to 2026 and Assoc. Vice President - Global Quality Auditing and Compliance from 2020 to 2023.
Jenny Little (Hodson)
LinkedInExperience: Asociate Vice President - PR01 Site Head · Eli Lilly and Company
Jenny Little has been Asociate Vice President - PR01 Site Head at Eli Lilly and Company since July 2026, based in Puerto Rico. At Eli Lilly and Company, Jenny Little was also Associate Vice President - Biotech Plant Manager from 2024 to 2026, Associate Vice President, Technical Services and Manufacturing Science from 2022 to 2024 and Sr Director, Aseptic Operations / Plant Manager from 2020 to 2022.
Kazunari Nishiguchi
LinkedInExperience: Sr.Director, Japan Local Controller · Eli Lilly and Company
Kazunari Nishiguchi has been Sr.Director, Japan Local Controller at Eli Lilly and Company since February 2026, based in Osaka. At Eli Lilly and Company, Kazunari Nishiguchi was also Head of Alliance Management from 2023 to 2026, Associate Director Business Development and Alliance Management from 2022 to 2023 and FP&A Manager from 2019 to 2022.
Mo Behbahani
LinkedInExperience: Sr. Vice President & Site Head/General Manager- Drug Substance, API Manufacturing · Eli Lilly and Company
Mo Behbahani has been Sr. Vice President & Site Head/General Manager- Drug Substance, API Manufacturing at Eli Lilly and Company since July 2026, based in Indianapolis. At Eli Lilly and Company, Mo Behbahani was also Vice President –Site Head/General Manager – Injectable Drug Product Mfg., Devices, Packaging Ops from 2023 to 2026 and Vice President – Site Head/General Manager – Injectable Drug Product Mfg. & Packaging Operations from 2021 to 2023.
Rosa Manso
LinkedInExperience: Vice President - Site Head · Eli Lilly and Company
Rosa Manso has been Vice President - Site Head at Eli Lilly and Company since August 2026, in a role based in Sesto Fiorentino, Italy. At Eli Lilly and Company, Rosa Manso was also Site Head - Concord from 2022 to 2026, Head of Aseptic Operations / Parenteral Plant leader from 2019 to 2022 and Director, Engineering from 2017 to 2019.
Choose the right perspective
Match the person's function to your question, since a manufacturing site head and a finance director see different parts of the business. People who held other Eli Lilly roles before their current one can also speak to how the work changed with the new title.
Questions to take into the conversation
- 01What did you focus on in your first months in your current role?
- 02Which parts of your past roles have been most useful in the role you hold now?
- 03How do you decide which priorities to take on first when you step into a larger role?
Reaching Eli Lilly leaders in new roles in 2026
How can I contact one of these Eli Lilly leaders in new roles in 2026?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 1 company: Eli Lilly and Company, based on profile data retrieved on October 25, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Eli Lilly leaders in new roles in 2026?
You choose the offer, starting at $5 per person. The offer is what the person receives, and Instant Expert's fee is added on top, so a $100 offer costs you $125. The fee is 20% of what you pay. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
Can an AI agent ask one of these Eli Lilly leaders in new roles in 2026 a question?
Yes. An agent with a USDC wallet on Base can ask one question without an Instant Expert account. It names the person, for example by the LinkedIn URL on this page, and pays per ask over x402 (HTTP 402). The person answers in writing or by voice note, and if nobody answers within 7 days, the payment goes back to the wallet automatically. Claude and ChatGPT can do the same through the Instant Expert connector: setup is at /docs/mcp for Claude and /docs/chatgpt for ChatGPT. x402 docs
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.